GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK price to free cash flow
Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.
GSK's price to free cash flow was 12.0× on Oct 19, 2026, against 14.3× a year earlier. Over the last 5 years it ranged from 7.6× to 17.7×, with a median of 11.3×.
Price to Free Cash Flow at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 12.0× | −2.6 |
| 2025 | Dec 31, 2025 | 14.7× | +4.5 |
| 2024 | Dec 31, 2024 | 10.2× | +0.7 |
| 2023 | Dec 29, 2023 | 9.5× | +1.1 |
| 2022 | Dec 30, 2022 | 8.4× | −2.4 |
| 2021 | Dec 31, 2021 | 10.8× | +1.0 |
| 2020 | Dec 31, 2020 | 9.8× | −2.4 |
| 2019 | Dec 31, 2019 | 12.2× | −1.3 |
| 2018 | Dec 31, 2018 | 13.5× | +0.8 |
| 2017 | Dec 29, 2017 | 12.7× | −50.2 |
| 2016 | Dec 30, 2016 | 62.9× | – |